InsidersTradesSigma
Track the 蔚蓝生物 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 蔚蓝生物 has recorded 6 reports. Market capitalisation: €2.8bn. The latest transaction was filed on 28 March 2025 (Sale). Among the most active insiders: 贾德强. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
蔚蓝生物 is a company operating in the health and pharmaceutical sector, listed on the XSHG market. It focuses on developing innovative solutions to enhance human health.